Cucurbitacin I


CAS No. : 2222-07-3

Cucurbitacin I,2222-07-3
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000030
Synonyms:(8S,9R,10R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
Molecular Formula:C30H42O7
Molecular Weight:514.7
Target:JAK
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

refresh

Assay:≥98%
Appearance:A crystalline solid
Cat No:I000030
Cas No:2222-07-3
Product-Name:Cucurbitacin I
InChIKey:NISPVUDLMHQFRQ-MKIKIEMVSA-N

Cucurbitacin I is a naturally occurring triterpenoid derived from Cucurbitaceae family plants that exhibits a number of potentially useful pharmacological and biological activities.
IC50 value:
Target:
In vitro: Exposure of the COLO205 cells to cucurbitacin I significantly decreased cell viability. Furthermore our data demonstrated for the first time that in the COLO205 cells, cucurbitacin I could suppress the cell migration and invasion, and harbor chemosensitization activity against colon cancer. The anticancer activity of cucurbitacin I was accomplished by downregulating p-STAT3 and MMP-9 expression [1]. PE-induced cell enlargement and upregulation of ANF and β-MHC were significantly suppressed by pretreatment of the cardiomyocytes with cucurbitacin I. Notably, cucurbitacin I also impaired connective tissue growth factor (CTGF) and MAPK signaling, pro-hypertrophic factors, as well as TGF-β/Smad signaling, the important contributing factors to fibrosis. The protective impact of cucurbitacin I was significantly blunted in CTGF-silenced or TGF-β1-silenced hypertrophic cardiomyocytes, indicating that the compound exerts its beneficial actions through CTGF [2].
In vivo:


[1]. Song J, et al. Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer. Oncol Rep. 2015 Apr;33(4):1867-71.
[2]. Jeong MH, et al. Cucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF- β/Smads Signalings. PLoS One. 2015 Aug 21;10(8):e0136236.

Related Products
  • CAS No. :1187595-84-1
    Product Name:

    Baricitinib phosphate

    Cat No: I000675 View details
  • CAS No. :82058-16-0
    Product Name:

    NSC-33994

    Cat No: R056716 View details
  • CAS No. :1187594-09-7
    Product Name:

    Baricitinib

    Cat No: I000674 View details
  • CAS No. :1092578-47-6
    Product Name:

    (3S,4S)-Tofacitinib

    Cat No: I000385 View details